Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MONTRÉAL, QUÉBEC--(Marketwired - 15 juillet 2016) - LE PRÉSENT COMMUNIQUÉ DE PRESSE EST DESTINÉ À ÊTRE DISTRIBUÉ AU CANADA SEULEMENT ET...
-
MONTREAL, QUEBEC--(Marketwired - July 15, 2016) - THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...
-
MONTRÉAL, QUÉBEC et NEW YORK, NEW YORK--(Marketwired - 6 juillet 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société...
-
MONTREAL, QUEBEC and NEW YORK CITY, NEW YORK--(Marketwired - July 6, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, and Ember...
-
MONTREAL, QUEBEC--(Marketwired - June 16, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company") announced today that each director nominee listed in the Management...
-
MONTREAL, QUEBEC--(Marketwired - June 2, 2016) - Long Zone Holdings Inc. ("the Corporation") announced that pursuant to a previously announced prospectus offering ("the Offering") by...
-
MONTRÉAL, CANADA--(Marketwired - 2 juin 2016) - LE PRÉSENT COMMUNIQUÉ EST CENSÉ ÊTRE DIFFUSÉ AU CANADA UNIQUEMENT. IL NE DOIT PAS ÊTRE REMIS...
-
MONTREAL, CANADA--(Marketwired - June 2, 2016) - THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...
-
MONTREAL, QUEBEC--(Marketwired - May 31, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Jonathan Ross...
-
MONTREAL, CANADA--(Marketwired - May 10, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today reported...